Sign Up to like & get
recommendations!
0
Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.4.3352752
Abstract: Tanezumab is a novel humanized IgG2 monoclonal antibody that works by selectively targeting, binding to and inhibiting nerve growth factor (NGF). NGF is upregulated in response to injury and inflammation, and preclinical data indicate it…
read more here.
Keywords:
treatment osteoarthritis;
osteoarthritis pain;
pain;
tanezumab treatment ... See more keywords